StjersdwardJ.: Cancer pain relief: An import on global public health issue. In FieldsH.L.Advances in pain research and therapy, Raven PressNY, 1985; 9: 555–558
2.
BonicaJ.J.: Treatment of Cancer Pain: Current status and future needs. In FieldsH.L., Advances in pain research and therapy, Raven PressNY1985; 9: 589–616
3.
FoleyK.M.: The treatment of cancer pain. NEJM1985; 1985(2): 84–95
4.
FoleyK.M.: The cancer pain patient. Journal of Pain and Symptom Management1988; 1988(1): 516–19
5.
Health, and Public Policy Committee, American College of Physicians: Drug therapy for severe, chronic pain in terminal illness. Annals of Int Med1983; 99: 870–873
6.
FoleyK.M., InturissiC.E.: Analgesic and therapy in cancer pain: Principles and practice. Med Clinics of N.A.1987; 71: 207–232
7.
KannerR.M.: Pharmacological management of pain and symptom control in cancer. J of Pain and Symptom Management1987; 2: 19–22
8.
American Pain Society: Principles of analgesic use in the treatment of acute pain and chronic cancer pain1987
9.
TwycrossR.G.: Analgesics. Clinics in Oncology1984; 1984(1): 91–108
10.
A Report on the Wisconsin Cancer Pain Initiative. J of Pain and Symptom Management1988; 3(1): S2–5
11.
TwycrossR.G.: Incidence of pain. Clinics in Oncology1984; 3(1): 5–15
12.
CharapA.D.: The knowledge, attitudes, and experience of medical personnel treating pain in the terminally ill. The Mount Sinai J of Medicine1978; 1978(4), July-August: 561–580
13.
SriwatanakulK., WeisO.F., AllozaJ.L.: Analysis of narcotic analgesic usage in the treatment of postoperative pain. JAMA1983; 1983(7): 926–9
14.
MarksR.M., SacharE.J.: Undertreatment of medical inpatients with narcotic analgesics. Annals of Int Med1973; 78: 173–181
15.
KannerR.M., FoleyK.M.: Patterns of narcotic drug use in a cancer pain clinic. Annals of NY Academy of Science1981; 362: 161–172
16.
PorterJ., JickH.: Addiction rare in inpatients treated with narcotics. NEJM1980; 1980(2): 123
17.
MustoD.F.: The American antinarcotic movement: Clinical Research and public policy. Clinical Res1971; 19: 601–605
18.
MustoD.F.: Evaluation of American narcotics controls. In Drug use in America: Problem in perspective, the technical papers of the second report of the National Commission on Marijuana and Drug Abuse, U.S. Government Printing OfficeWashington, DC1973: 335–348
19.
U.S. Department of Justice Drug Enforcement Administration: Drugs of abuse.U.S. Government Printing OfficeWashington, DC1985
20.
Wisconsin Controlled Substances Board: Protecting your medical practice: A guide to prescribing controlled substances in Wisconsin, 1986
21.
U.S. Department of Just Drug Enforcement Administration: Multiple copy prescription programs. Resource Guide, 1987
22.
SiglerK.A., GuernseyB.G., IngrimN.B.: Effects of a triplicate prescription law on prescribing of Schedule II Drugs. Amer J of Hosp Pharm1984; 41: 108–111
23.
McGrewJ.L.: Federal regulation of the production, distribution and dispensing of drugs for prevention of diversion. In Drug use in America: Problem in perspective, the technical papers of the second report of the National Commission on Marijuana and Drug Abuse, VA Government Printing OfficeWashington, DC1973: 354–376
24.
MorganJ.P., PleetD.A.: Opiophobia in the United States: The undertreatment of severe pain. In MorganJ.P., KaganD.V., Society and Medication: Conflicting signals for prescribers and patients, Lexington BooksLexington, Mass.1983: 313–326
25.
AMA writes prescription for treating growing drug diversion problem. JAMA1987; 257(6): 725–726
26.
Drug abuse related to prescribing practices. JAMA1982; 247(6): 864–866
27.
KannerR.M., PortenoyR.N.: Unavailability of narcotic analgesics for ambulatory cancer patients in NYC. J of Pain and Symptom Management1986; 1: 87–89
28.
A Report on the Wisconsin Cancer Pain Initiative.J of Pain and Symptom Management1988; 3: 52–55
29.
TwycrossR.G.: Ethical and clinical aspects of pain treatment in cancer patients. Acta Anaesthiologica Scandinavica1982; 74: 83–90